Initial experience with thulium fiber laser for prostate enucleation: Analysis of the intraoperative and short-term outcomes in a prospective, multicenter cohort
J. Romero Otero , J. Justo Quintas , E. García Rojo , R. Sopeña Sutil , E. Peña Vallejo , F. Lista Mateos , G. Bozzini , D. Saenz Calzada , A. Rodríguez Antolín , B. García Gómez
{"title":"Initial experience with thulium fiber laser for prostate enucleation: Analysis of the intraoperative and short-term outcomes in a prospective, multicenter cohort","authors":"J. Romero Otero , J. Justo Quintas , E. García Rojo , R. Sopeña Sutil , E. Peña Vallejo , F. Lista Mateos , G. Bozzini , D. Saenz Calzada , A. Rodríguez Antolín , B. García Gómez","doi":"10.1016/j.acuroe.2024.02.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Holmium laser enucleation of the prostate has rapidly become the gold standard for the surgical treatment of benign prostate hyperplasia, although thulium fiber laser (TFL) has also been postulated as an effective and safe alternative for prostate enucleation. The aim of this study is to describe our initial experience with the TFL for endoscopic enucleation of the prostate.</p></div><div><h3>Material and methods</h3><p>All patients proposed to TFL prostate enucleation were included in the analysis, regardless their prostate volume, catheter status and severity of symptoms, in 3 centers. Preoperative characteristics, intraoperative times and functional 3-months follow-up variables were collected, along with complications.</p></div><div><h3>Results</h3><p>Fifty-six patients were available, with a mean age of 68.7 years. Enucleation and morcellation efficiencies were 2.04 and 7.47 g/min, respectively. Median hospital stay was one day. Comparable functional data, pre and 3-month post-surgery was: mean prostate volume 88.9 vs 21.3 g, maximum urinary flow 13.2 vs 27.3 ml/s, post-void residual volume 149 vs 7.8 ml, prostatic specific antigen level 11.2 vs 1 ng/ml, and International Prostate Symptom Score 20.75 vs 3.96. Fourteen out of 56 (25%) patients presented with complications grade ≤2, according to the Clavien-Dindo classification.</p></div><div><h3>Discussion</h3><p>With wider evidence for other urological indications, very recent evidence about the suitability of TFL for prostate enucleation has arisen, since the first case described in 2021. Our results seem to back up these previous successful experiences as long as we obtained good intraoperative and short term follow-up functional results. However, there is still a need of longer follow-up data.</p></div><div><h3>Conclusions</h3><p>TFL represents a novel technology for prostate enucleation, with a good intraoperative and short follow-up functional results, and a safety profile similar to the observed for those techniques that have been wider used for this indication. Further studies with longer follow-up periods and comparative with these other techniques are necessary.</p></div>","PeriodicalId":94291,"journal":{"name":"Actas urologicas espanolas","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Actas urologicas espanolas","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2173578624000179","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Holmium laser enucleation of the prostate has rapidly become the gold standard for the surgical treatment of benign prostate hyperplasia, although thulium fiber laser (TFL) has also been postulated as an effective and safe alternative for prostate enucleation. The aim of this study is to describe our initial experience with the TFL for endoscopic enucleation of the prostate.
Material and methods
All patients proposed to TFL prostate enucleation were included in the analysis, regardless their prostate volume, catheter status and severity of symptoms, in 3 centers. Preoperative characteristics, intraoperative times and functional 3-months follow-up variables were collected, along with complications.
Results
Fifty-six patients were available, with a mean age of 68.7 years. Enucleation and morcellation efficiencies were 2.04 and 7.47 g/min, respectively. Median hospital stay was one day. Comparable functional data, pre and 3-month post-surgery was: mean prostate volume 88.9 vs 21.3 g, maximum urinary flow 13.2 vs 27.3 ml/s, post-void residual volume 149 vs 7.8 ml, prostatic specific antigen level 11.2 vs 1 ng/ml, and International Prostate Symptom Score 20.75 vs 3.96. Fourteen out of 56 (25%) patients presented with complications grade ≤2, according to the Clavien-Dindo classification.
Discussion
With wider evidence for other urological indications, very recent evidence about the suitability of TFL for prostate enucleation has arisen, since the first case described in 2021. Our results seem to back up these previous successful experiences as long as we obtained good intraoperative and short term follow-up functional results. However, there is still a need of longer follow-up data.
Conclusions
TFL represents a novel technology for prostate enucleation, with a good intraoperative and short follow-up functional results, and a safety profile similar to the observed for those techniques that have been wider used for this indication. Further studies with longer follow-up periods and comparative with these other techniques are necessary.
导言:钬激光前列腺去核术已迅速成为手术治疗良性前列腺增生的金标准,尽管铥光纤激光(TFL)也被认为是前列腺去核术的一种有效而安全的替代方法。本研究旨在介绍我们使用铥光纤激光器进行内窥镜前列腺去核术的初步经验:分析对象包括3个中心所有拟行TFL前列腺摘除术的患者,无论其前列腺体积、导管状态和症状严重程度如何。收集了术前特征、术中时间、3个月功能随访变量以及并发症:结果:共有 56 名患者接受了手术,平均年龄为 68.7 岁。去核和去骨效率分别为2.04克/分钟和7.47克/分钟。住院时间中位数为一天。手术前和手术后三个月的功能数据比较如下:前列腺平均体积 88.9 vs 21.3 g,最大尿流 13.2 vs 27.3 ml/s,排尿后残余体积 149 vs 7.8 ml,前列腺特异抗原水平 11.2 vs 1 ng/ml,国际前列腺症状评分 20.75 vs 3.96。根据克拉维恩-丁多分类法,56名患者中有14名(25%)出现了≤2级并发症:讨论:随着其他泌尿外科适应症的证据越来越多,自2021年描述第一例前列腺摘除术以来,关于TFL是否适合前列腺摘除术的证据也在不断涌现。只要我们获得良好的术中和短期随访功能结果,我们的结果似乎就能证明之前的成功经验。然而,我们仍需要更长期的随访数据:结论:TFL是前列腺去核术的一种新技术,术中和短期随访功能结果良好,安全性与已广泛应用于该适应症的技术相似。有必要进行更长时间的随访研究,并与其他技术进行比较。